Atea Pharmaceuticals Inc. (AVIR)
NASDAQ · Healthcare
Atea Pharmaceuticals Inc. EBITDA 2020–2021
Atea Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2020 to 2021. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Atea Pharmaceuticals Inc. ebitda for the quarter ending March 31, 2021 was 30.7 M.
- Atea Pharmaceuticals Inc. annual ebitda for 2021 was 138.4 M, a 1356.98% decrease from 2020.
- Atea Pharmaceuticals Inc. annual ebitda for 2020 was -11.0 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Atea Pharmaceuticals Inc. EBITDA — FAQ
Atea Pharmaceuticals Inc. (AVIR) ebitda over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVIR's ebitda history?
The chart and table above show Atea Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.